Company Overview and News

3
Radcom - Major Credibility Erosion After Recent Events

2018-09-21 seekingalpha - 1
Company loses two key executives within one week, causing a major sell-off in the company's shares.
RDCM GLO T GTMEY VZ GTMEF GLOPP GLOPA VZA

1
Selection of third major telco on track by December as gov’t issues final terms

2018-09-21 bworldonline
THE DEPARTMENT of Information and Communications Technology (DICT) and the National Telecommunications Commission (NTC) published on Friday the final terms of reference (ToR) outlining the process by which the government will select by December a third major player in the telecommunications industry.
K3ED CHJHF NOW GTMEY CHA ECP GLOPP GLO KT 0728 GTMEF GLOPA DNOW

 
Nuage Networks unveils SD-WAN 2.0, the industry's only automated and secure services platform for the delivery of enterprise IT services across any network and cloud

2018-09-19 globenewswire
Espoo, Finland - Nokia is introducing the latest release of the Nuage Networks Virtualized Network Services (VNS) platform, offering the most powerful and secure end-to-end network governance across a multi-cloud environment, with complete visibility and control from a single management interface. Nuage Networks VNS is the industry's first and only SD-WAN 2.0 offering that is more than a network connectivity platform, providing a services architecture to deliver and orchestrate enterprise IT services across data centers, public cloud services, SaaS provider clouds and enterprise branch sites.
GLO GTMEY GTMEF GLOPP GLOPA

 
The rise of eSports in the Philippines

2018-09-19 bworldonline
Though the industry takes its roots in the 2000s, the international eSports scene did not see much traction until early this decade, when the participation of professional players and the advent of livestreaming and sponsorships became mainstream.
GLO GTMEY GTMEF GLOPP GLOPA

 
AC expects delivery platform to boost logistics business

2018-09-17 bworldonline
AYALA CORP. (AC) aims to grow its newly formed Entrego delivery platform into one of the leading third-party logistics players in the future, as the conglomerate further ramps up its investments in the country’s booming logistics sector.
AC GLO MPCFF MPCIY MPI GTMEY GTMEF GLOPP GLOPA

 
Beyond the call of duty: Network Engineer rescues more than just damaged cell sites

2018-09-13 business.inquirer.net
As their call of duty, field operations engineers are expected to keep communication lines up and running during calamities and disasters. But one of them, 36-year-old Joel Gonzales, recently showed what public service is all about by going beyond his mandate.
GLO GTMEY GTMEF GLOPP GLOPA

 
Duterte to select country’s 3rd telco player by Christmas

2018-09-12 newsinfo.inquirer.net
President Rodrigo Duterte said his office would pick the country’s third telecommunications player in December if the selection process remained unresolved by November.
GLO GTMEY GTMEF GLOPP GLOPA

 
PSEI down on high inflation, currency jitters

2018-09-05 business.inquirer.net
The local stock barometer slid below the crucial 7,800 mark on Wednesday as investors were spooked by higher-than-expected Philippine August inflation alongside emerging market contagion jitters.
SVTMF PSKXF GTMEY AYAAY SM GLOPP GLO SMIVY PHSXY GTMEF PSE GLOPA ALI AYAAF

 
Globe intensifies drive to recover PH’s severely depleted primary rainforests

2018-09-05 business.inquirer.net
Globe Telecom, together with Hineleban Foundation, Inc., has launched an intensive drive to educate the public and raise awareness about the severe state of Philippine primary rainforests that only have 1.5% of its cover remaining.
GLO GTMEY GTMEF GLOPP GLOPA

 
Globe expands LTE network coverage

2018-09-04 bworldonline
Globe Telecom, Inc. said it installed 1,752 new long-term evolution (LTE) sites during the first half of the year, bringing its LTE network coverage to reach almost 95% of cities and municipalities all over the country.
GLO GTMEY GTMEF GLOPP GLOPA

 
Philippines channels India with ID system to get poorest on map

2018-08-30 bworldonline
“Like an alien,” is how the housekeeper in Manila describes what she felt when she discovered she had no birth record.
GLO ABTZY GTMEY GTMEF AEV GLOPP GLOPA

 
PH stocks rally back to 7,800

2018-08-28 business.inquirer.net
The local stock barometer breached the 7,800 barrier on Tuesday, drawing strength from upbeat US and regional markets.
GLO PSKXF GTMEY AYAAY PHSXY PSE GTMEF GLOPP GLOPA ALI AYAAF

 
DICT studying higher fees to force return of underused frequency

2018-08-26 bworldonline
THE Department of Information and Communications Technology (DICT) said it is studying raising user fees for under-utilized frequency owned by telecommunications companies.
GLO GTMEY GTMEF GLOPP GLOPA

 
CIMB Philippines inks deal with Ant Financial's unit to create, market financial products in Philippines

2018-08-24 theedgemarkets
KUALA LUMPUR (Aug 24): CIMB Group Holdings Bhd said CIMB Bank Philippines (CIMB Philippines) today signed a Memorandum of Agreement with G-Xchange, Inc (GXI) to create and market innovative financial products on GXI’s digital platform in the Philippines.
1023 GLO GTMEY GTMEF GLOPP GLOPA CIMDF

 
NGCP denies talks on internet over power lines

2018-08-23 business.inquirer.net
Transmission superhighway operator National Grid Corp. of the Philippines (NGCP) has denied having discussions with Laguna-based electronics manufacturer Cirtek Holdings Philippines Corp. on using the national grid for mobile infrastructure.
GLO TECH NG GTMEY NGGTF GTMEF GLOPP GLOPA NGG

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...